PSS2 COSTO-EFECTIVIDAD DEL USO DE ETANERCEPT VS LOS ANTICUERPOS MONOCLONALES ANTI-TNF EN PACIENTES CON PSORIASIS EN PLACAS EN MXICO
Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)75499-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)75499-1/fulltext
Section Title :
Section Order :
1421
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75499-1&doi=10.1016/S1098-3015(10)75499-1